There has been growing interest in using oxytocin as a pharmacotherapy for psychiatric disorders, including substance use disorder. Limited data exist regarding oxytocin’s reinforcing efficacy, which is a necessary consideration for novel pharmacotherapies, especially in substance-using populations.
Aims:
This study aimed to determine the potential reinforcing effects of intranasally administered oxytocin by assessing behavioral economic demand and subjective effects.
Methods:
Healthy adults (n = 23) participated in a double-blind, repeated-measures, laboratory study wherein they received intranasal oxytocin (40 IU) or placebo in a randomized order across two sessions. Participants completed drug purchasing tasks at the conclusion of both sessions. Throughout both sessions, subjective and physiological effects were assessed.
Results:
Demand-curve analysis of purchasing tasks revealed greater median purchasing for oxytocin relative to placebo. Physiological and subjective effects did not significantly differ between oxytocin and placebo. However, a nonsignificant trend was observed for moderately greater drug liking for oxytocin relative to placebo. There was a significant, positive correlation between the difference in drug liking (between oxytocin and placebo) and the difference in lowest-price purchasing (between oxytocin and placebo).
Conclusions:
These data suggest the potential for limited reinforcing and abuse-related subjective effects of intranasal oxytocin. Given the small sample, the greater drug liking of oxytocin compared to placebo, and the positive relation between demand and drug liking, it is possible that oxytocin may produce reinforcing effects in some participants. Therefore, additional studies of oxytocin reinforcement are warranted.
AlfvenG (2004) Plasma oxytocin in children with recurrent abdominal pain. J Pediatr Gastroenterol Nutr38: 513–517.
2.
American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, Virginia: American Psychiatric Association.
3.
AnagnostouESooryaLChaplinW, et al. (2012) Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: A randomized controlled trial. Mol Autism3: 16.
4.
AnderbergUMUvnas-MobergK (2000) Plasma oxytocin levels in female fibromyalgia syndrome patients. Z Fur Rheumatol59: 373–379.
5.
AstonERMetrikJMacKillopJ (2015) Further validation of a marijuana purchase task. Drug Alcohol Depen152: 32–38.
6.
BershadAKWeaferJJKirkpatrickMG, et al. (2016) Oxytocin receptor gene variation predicts subjective responses to MDMA. Social Neurosci11: 592–599.
7.
BickelWKMaddenGJ (1999) A comparison of measures of relative reinforcing efficacy and behavioral economics: Cigarettes and money in smokers. Behav Pharmacol10: 627–637.
8.
BorlandJMRillingJKFrantzKJ, et al. (2019) Sex-dependent regulation of social reward by oxytocin: An inverted U hypothesis. Neuropsychopharmacology44: 97–110.
9.
BrunerNRJohnsonMW (2014) Demand curves for hypothetical cocaine in cocaine-dependent individuals. Psychopharmacology231: 889–897.
10.
BusnelliMDaganiJDe GirolamoG, et al. (2016) Unaltered oxytocin and vasopressin plasma levels in patients with schizophrenia after 4 months of daily treatment with intranasal oxytocin. J Neuroendocrinol28.
11.
CampbellDBDattaDJonesST, et al. (2011) Association of oxytocin receptor (OXTR) gene variants with multiple phenotype domains of autism spectrum disorder. J Neurodev Disord3: 101–112.
12.
CarbonaroTMJohnsonMWHurwitzE, et al. (2018) Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: Similarities and differences in subjective experiences. Psychopharmacology235: 521–534.
13.
CarsonDSCornishJLGuastellaAJ, et al. (2010) Oxytocin decreases methamphetamine self-administration, methamphetamine hyperactivity, and relapse to methamphetamine-seeking behaviour in rats. Neuropharmacology58: 38–43.
14.
ConeEJBigelowGEHerrmannES, et al. (2015) Nonsmoker exposure to secondhand cannabis smoke. III. Oral fluid and blood drug concentrations and corresponding subjective effects. J Anal Toxicol39: 497–509.
15.
de WitHUhlenhuthEHJohansonCE (1986) Individual differences in the reinforcing and subjective effects of amphetamine and diazepam. Drug Alcohol Depend16: 341–360.
16.
DolderPCMullerFSchmidY, et al. (2018) Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects. Psychopharmacology235: 467–479.
17.
DumaisKMVeenemaAH (2016) Vasopressin and oxytocin receptor systems in the brain: Sex differences and sex-specific regulation of social behavior. Front Neuroendocrinol40: 1–23.
18.
FlanaganJCAllanNPCalhounCD, et al. (2018a) Effects of oxytocin on stress reactivity and craving in veterans with co-occurring PTSD and alcohol use disorder. Exp Clin Psychopharmacol27: 45–54.
19.
FlanaganJCSippelLMWahlquistA, et al. (2018b) Augmenting prolonged exposure therapy for PTSD with intranasal oxytocin: A randomized, placebo-controlled pilot trial. J Psychiatr Res98: 64–69.
20.
FrijlingJL (2017) Preventing PTSD with oxytocin: Effects of oxytocin administration on fear neurocircuitry and PTSD symptom development in recently trauma-exposed individuals. Eur J Psychotraumatol8: 1302652.
21.
GaoSBeckerBLuoL, et al. (2016) Oxytocin, the peptide that bonds the sexes also divides them. Proc Natl Acad Sci U S A113: 7650–7654.
22.
GarrettBEGriffithsRR (2001) Intravenous nicotine and caffeine: Subjective and physiological effects in cocaine abusers. J Pharmacol Exp Ther296: 486–494.
23.
GoodinBRAndersonAJBFreemanEL, et al. (2015) Intranasal oxytocin administration is associated with enhanced endogenous pain inhibition and reduced negative mood states. Clin J Pain31: 757–767.
24.
GriffithsRRBigelowGEAtorNA (2003) Principles of initial experimental drug abuse liability assessment in humans. Drug Alcohol Depend70(3 Suppl): S41–S54.
25.
HigginsSTHeilSHSigmon, et al. (2017) Addiction potential of cigarettes with reduced nicotine content in populations with psychiatric disorders and other vulnerabilities to tobacco addiction. JAMA Psychiatry74: 1056–1064.
26.
HudziakJJHelzerJEWetzelMW, et al. (1993) The use of the DSM-III-R checklist for initial diagnostic assessments. Compr Psychiatry34: 375–383.
27.
HurshSRSilberbergA (2008) Economic demand and essential value. Psychol Rev115: 186–198.
JohnsonMWHerrmannESSweeneyMM, et al. (2017) Cocaine administration dose-dependently increases sexual desire and decreases condom use likelihood: The role of delay and probability discounting in connecting cocaine with HIV. Psychopharmacology234: 599–612.
30.
KimYREomJSYangJW, et al. (2015) The impact of oxytocin on food intake and emotion recognition in patients with eating disorders: A double blind single dose within-subject cross-over design. PLoS One10: e0137514.
31.
KimYRKimCHCardiV, et al. (2014) Intranasal oxytocin attenuates attentional bias for eating and fat shape stimuli in patients with anorexia nervosa. Psychoneuroendocrinology44: 133–142.
32.
KirkpatrickMGBaggottMJMendelsonJE, et al. (2014b) MDMA effects consistent across laboratories. Psychopharmacology231: 3899–3905.
33.
KirkpatrickMGLeeRWardleMC, et al. (2014a) Effects of MDMA and intranasal oxytocin on social and emotional processing. Neuropsychopharmacology39: 1654–1663.
34.
KohtzASLinBSmithME, et al. (2018) Attenuated cocaine-seeking after oxytocin administration in male and female rats. Psychopharmacology235: 2051–2063.
35.
KovácsCLVan ReeJM (1985) Behaviorally active oxytocin fragments simultaneously attenuate heroin self-administration and tolerance in rats. Life Sci37: 1895–1900.
36.
KovácsGLBorthaiserZTelegdyG (1985) Oxytocin reduces intravenous heroin self-administration in heroin-tolerant rats. Life Sci37: 17–26.
37.
KruppaJAGossenAOberwelland WeissE, et al. (2018) Neural modulation of social reinforcement learning by intranasal oxytocin in male adults with high-functioning autism spectrum disorder: A randomized trial. Neuropsychopharmacology44: 749–756.
38.
LangesaeterERosselandLAStubhaugA (2006) Hemodynamic effects of oxytocin during cesarean delivery. Int J Gynaecol Obstet95: 46–47.
39.
LeeMRRohnMCTandaG, et al. (2016) Targeting the oxytocin system to treat addictive disorders: Rationale and progress to date. CNS Drugs30: 109–123.
40.
LuoLBeckerBGengY, et al. (2017) Sex-dependent neural effect of oxytocin during subliminal processing of negative emotion faces. Neuroimage162: 127–137.
41.
MaXZhaoWLuoR, et al. (2018) Sex- and context-dependent effects of oxytocin on social sharing. Neuroimage183: 62–72.
42.
MacKillopJGoldensonNIKirkpatrickMG, et al. (2018) Validation of a behavioral economic purchase task for assessing drug abuse liability. Addict Biol24: 303–314.
43.
MoreanMEDe WitHKingAC, et al. (2013) The drug effects questionnaire: Psychometric support across three drug types. Psychopharmacology227: 177–192.
44.
MurphyJGMacKillopJ (2006) Relative reinforcing efficacy of alcohol among college student drinkers. Exp Clin Psychopharmacol14: 219–227.
45.
NajaWJAounMP (2017) Oxytocin and anxiety disorders: Translational and therapeutic aspects. Curr Psychiatry Rep19: 67.
46.
NormanGJCacioppoJTMorrisJS, et al. (2011) Oxytocin increases autonomic cardiac control: Moderation by loneliness. Biol Psychol86: 174–180.
47.
QiJYangJYWangF, et al. (2009) Effects of oxytocin on methamphetamine-induced conditioned place preference and the possible role of glutamatergic neurotransmission in the medial prefrontal cortex of mice in reinstatement. Neuropharmacology56: 856–865.
48.
RashJACampbellTS (2014) The effect of intranasal oxytocin administration on acute cold pressor pain: A placebo-controlled, double-blind, within-participants crossover investigation. Psychosom Med76: 422–429.
49.
ReedSCHaneyMManubayJ, et al. (2019) Sex differences in stress reactivity after intranasal oxytocin in recreational cannabis users. Pharmacol Biochem Behav176: 72–82.
50.
RomneyCHahn-HolbrookJNormanGJ, et al. (2018) Where is the love? A double-blind, randomized study of the effects of intranasal oxytocin on stress regulation and aggression. Int J Psychophysiol136: 15–21.
51.
RosselandLAHaugeTHGrindheimG, et al. (2013) Changes in blood pressure and cardiac output during cesarean delivery: The effects of oxytocin and carbetocin compared with placebo. Anesthesiology119: 541–551.
52.
RussellJMaguireSHuntGE, et al. (2018) Intranasal oxytocin in the treatment of anorexia nervosa: Randomized controlled trial during re-feeding. Psychoneuroendocrinology87: 83–92.
53.
SmithTTCassidyRNTideyJW, et al. (2017) Impact of smoking reduced nicotine content cigarettes on sensitivity to cigarette price: Further results from a multi-site clinical trial. Addiction112: 349–359.
54.
StaufferCSMusinipallyVSuenA, et al. (2016) A two-week pilot study of intranasal oxytocin for cocaine-dependent individuals receiving methadone maintenance treatment for opioid use disorder. Addict Res Theory24: 490–498.
55.
StricklandJCLileJAStoopsWW (2017) Unique prediction of cannabis use severity and behaviors by delay discounting and behavioral economic demand. Behav Proc140: 33–40.
56.
TachibanaMKagitani-ShimonoKMohriI, et al. (2013) Long-term administration of intranasal oxytocin is a safe and promising therapy for early adolescent boys with autism spectrum disorders. J Child Adolesc Psychopharmacol23: 123–127.
57.
Van HedgerKBershadAKLeeR, et al. (2020) Effects of intranasal oxytocin on stress-induced cigarette craving in daily smokers. Nicotine Tob Res22: 89–95.
58.
Van HedgerKKushnerMJLeeR, et al. (2019) Oxytocin reduces cigarette consumption in daily smokers. Nicotine Tob Res21: 799–804.
59.
VandreyRHerrmannESMitchellJM, et al. (2017) Pharmacokinetic profile of oral cannabis in humans: Blood and oral fluid disposition and relation to pharmacodynamic outcomes. J Anal Toxicol41: 83–99.
60.
VenaAKingALeeR, et al. (2018) Intranasal oxytocin does not modulate responses to alcohol in social drinkers. Alcohol Clin Exp Res42: 1725–1734.
61.
WardleMCMarcusBADe WitH (2015) A preliminary investigation of individual differences in subjective responses to D-amphetamine, alcohol, and delta-9-tetrahydrocannabinol using a within-subjects randomized trial. PLoS One10: e0140501.
62.
WeisFRJrMarkelloRMoB, et al. (1975) Cardiovascular effects of oxytocin. Obstet Gynecol46: 211–214.
63.
WilsonAGFranckCTKoffarnusMN, et al. (2016) Behavioral economics of cigarette purchase tasks: Within-subject comparison of real, potentially real, and hypothetical cigarettes. Nicotine Tob Res18: 524–530.
64.
WoolleyJDArcuniPAStaufferCS, et al. (2016) The effects of intranasal oxytocin in opioid-dependent individuals and healthy control subjects: A pilot study. Psychopharmacology233: 2571–2580.
65.
World Health Organization (2011) WHO recommendation on use of intravenous oxytocin alone for induction of labor. The WHO Reproductive Health Library. Geneva: WHO.
66.
YamasueHOkadaTMunesueT, et al. (2018) Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder: A randomized clinical trial. Mol Psychiatry. 29 June 2018. DOI: 10.1038/s41380–018–0097–2.
67.
YamasueHYeeJRHurlemannR, et al. (2012) Integrative approaches utilizing oxytocin to enhance prosocial behavior: From animal and human social behavior to autistic social dysfunction. J Neurosci32: 14109–14117.
